Preclinical research is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2025-10-10. Numbers and descriptions here follow the published literature rather than marketing material.
The full name often given is N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide. This name indicates a chain containing tyrosine, isoleucine, and a six-carbon amino acid derivative. Databases list a CAS Registry Number and a molecular formula for the compound. The peptide is small compared with proteins, and its structure allows it to be studied in cell cultures and animal models. Exact identity depends on the supplier's synthesis and purification process. Minor impurities can remain after synthesis.
Chemically, dihexa belongs to a broader group of angiotensin IV analogs. Researchers have modified the natural peptide to alter stability, binding, or distribution. Such changes can affect how the molecule behaves in experiments. The parent peptide angiotensin IV is involved in various physiological processes, but the modified analog is not identical to it. Public summaries sometimes blur the distinction between the natural fragment and the synthetic research compound. This distinction matters when interpreting study results.
Dihexa is a synthetic peptide that has been examined in laboratory and animal research. Its design is based on angiotensin IV, a naturally occurring peptide fragment produced in the body. The short name dihexa appears in scientific papers and online discussions, while the full chemical name describes a modified peptide chain. It is not a vitamin, mineral, or plant-derived compound. Suppliers typically present it as a research chemical rather than an approved medicine.
The proposed mechanism involves interaction with the hepatocyte growth factor (HGF) system and its receptor, c-Met. Dihexa is described in some studies as an HGF mimetic, meaning it may mimic or enhance HGF-mediated signaling. Activation of c-Met can influence cell growth, survival, and cytoskeletal remodeling, pathways that intersect with synaptic plasticity. However, the precise binding targets and downstream events for dihexa are not fully established, and alternative mechanisms have been suggested.
Dihexa is a synthetic peptide with the chemical name N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide, and it is structurally related to angiotensin IV, a naturally occurring peptide fragment. Researchers developed it as a modified analog intended to alter stability and activity relative to the parent peptide. Its short sequence and fatty acid chain distinguish it from many endogenous peptides, and published studies often describe it under the abbreviation dihexa. The compound is classified as a laboratory compound rather than an approved therapeutic in most jurisdictions.
| Property | Value | Notes |
|---|---|---|
| Common name | Dihexa | Shorthand used in research literature and supplier catalogs. |
| CAS Registry Number | 1401708-83-5 | Identifier assigned to the synthetic peptide. |
| Molecular formula | C27H44N4O5 | Reported formula; verify with a certificate of analysis. |
| Appearance | White to off-white powder | Typical form for lyophilized research peptides. |
| Typical storage | −20 °C or below, desiccated | Common condition for peptide stability. |
Human safety data are sparse. No widely accepted dosing regimen, long-term safety profile, or clinical efficacy endpoint has been established. Published animal results can suggest directions for further study, but species differences and study design limit direct translation. Open questions include bioavailability, blood-brain barrier penetration, metabolism, and whether observed effects arise from a single target or multiple pathways. Replication across independent laboratories remains an important benchmark for evaluating the strength of preclinical claims.
Most published reports on dihexa come from cell cultures and animal models. Studies have examined markers of synapse formation, dendritic spine density, and performance on learning tasks in rodents. Proposed mechanisms center on hepatocyte growth factor and its c-Met receptor, with additional attention to angiotensin IV-related pathways. These findings are experimental and have not been confirmed as clinical benefits in humans. The literature often uses different tasks and endpoints, which complicates direct comparison across studies.
Laboratory characterization of dihexa typically relies on reverse-phase high-performance liquid chromatography for purity and mass spectrometry for identity. These methods are standard for synthetic peptides and help distinguish the target compound from related impurities or degradation products. Because dihexa is a small peptide-like molecule, it may be susceptible to hydrolysis under certain conditions. Storage recommendations generally emphasize low temperature, dryness, and protection from light. Analytical certificates from suppliers vary in detail, so independent verification can be important for research use.
Reported effects of dihexa are often described in terms of synaptogenesis, a process by which neurons form new synaptic connections. This concept is biologically plausible but difficult to measure directly in living humans. Animal behavioral tests can suggest memory or learning changes, yet such tests have limitations and may not translate to people. The literature includes conflicting or incomplete findings, and some studies are small. As a result, the mechanism remains a subject of investigation rather than a settled explanation.
The proposed mechanism of dihexa involves activation of hepatocyte growth factor and its receptor, c-Met. In cell models, this signaling pathway is associated with dendritic spine formation and synaptic reorganization. Dihexa is described as a stabilized analog of angiotensin IV, which also interacts with related systems. However, the precise binding profile and downstream effects remain incompletely characterized. Most mechanistic evidence comes from in vitro assays and rodent studies rather than human trials.
The proposed mechanism for dihexa centers on hepatocyte growth factor, or HGF, and its receptor c-Met. HGF signaling is involved in cell growth, survival, and synapse formation. Dihexa has been described as an HGF mimetic or modulator in preclinical literature. Whether it binds c-Met directly, increases HGF availability, or acts through another route remains uncertain. This mechanistic uncertainty is a recurring theme in reviews of the compound, and no single molecular model has been confirmed across independent laboratories.
Research on dihexa has primarily used rodent models and cultured cells. Common endpoints include dendritic spine density, synaptic protein expression, and performance on maze or avoidance tasks. Some studies report improvements in cognitive measures after scopolamine-induced deficits or in aged animals. These findings are interesting but come from a small body of work, and independent laboratories have not consistently replicated all reported effects. Larger, preregistered studies would help clarify which results are robust.
Identity and purity of dihexa samples are typically assessed with high-performance liquid chromatography and mass spectrometry. These methods can confirm molecular mass and estimate the presence of impurities. However, a certificate of analysis from a supplier is not a guarantee of independent testing. Researchers often require in-house verification before using a peptide in experiments. For solid samples, appearance, solubility, and chromatographic profile provide additional checks. Nuclear magnetic resonance may be used for structural confirmation when available.
Dihexa is commonly handled as a lyophilized powder in laboratory settings. Storage at -20 °C in a desiccated, light-protected container is typical for peptides. Repeated freeze-thaw cycles can degrade the material, so aliquoting is often recommended. Aqueous solutions may be less stable than organic stocks and should be prepared fresh when possible. Personnel should follow institutional safety procedures and avoid uncontrolled exposure. Because human effects are not well characterized, handling precautions are prudent.
The proposed mechanism of dihexa centers on activation of the hepatocyte growth factor receptor, also called c-Met. Some studies suggest it acts as a mimetic of hepatocyte growth factor, promoting signaling pathways involved in synapse formation. Other work has explored interactions with angiotensin IV pathways, but the exact binding targets remain uncertain. Laboratory findings come mainly from cell cultures and animal models. Whether these mechanisms operate similarly in humans is an open question. Researchers have not established a single, universally accepted mechanism of action.
In August 2024, a leaked report revealed that the unit had experienced an outbreak of a dangerous bacterium during the period in which the infants Letby was convicted of murdering died. The outbreak had not been mentioned during the trials. Commenting on the report, medical microbiologist David Livermore argued that the outbreak offered a simpler explanation for the rise in deaths than deliberate harm.
Vasopressin is released into the brain in a circadian rhythm by neurons of the suprachiasmatic nucleus. Vasopressin released from posterior pituitary is associated with nausea. Recent evidence suggests that vasopressin may have analgesic effects. The analgesia effects of vasopressin were found to be dependent on both stress and sex.
In early December 2025, Colombian president Petro's personal lawyer filed a complaint with the Inter-American Commission on Human Rights (IACHR) against Hegseth on behalf of Carranza's family. According to CNN, the sister of the Ecuadorian survivor of the 16 October strike, repatriated to Ecuador, "claim[ed] to know nothing of her brother's alleged involvement with drug trafficking and instead portrayed him as a desperate father trying to provide for his six kids". The Ecuadorian had been convicted and deported from the US in 2020 for drug smuggling. The Ecuadorian attorney general's office stated that no crime reports had been filed against him with their institution, so absent evidence for detaining him, the subject was released. The other survivor of the 16 October strike, repatriated to Colombia, was hospitalized upon arrival with moderate injuries, including a skull fracture. Petro and Armando Benedetti, Colombian Minister of the Interior, said at the time he was repatriated the survivor would be "prosecuted according to the law, because he is allegedly a criminal who was trafficking drugs". However, because the incident occurred in international waters, outside Colombian territory, he would only be prosecuted if he voluntarily spoke and incriminated himself. He was released on 6 November with no charges.
=== Light microscopy === Light microscopy can be used to magnify the structure of dinosaur eggshell for scientific research. To do so an eggshell fragment must be embedded in epoxy resin and sliced into a thin section with a thin-bladed rock saw. This basic method was invented by French paleontologist Paul Gervais and has remained almost unchanged ever since. Horizontally cut thin sections are called tangential thin sections while vertically cut thin sections are called radial sections. Regardless of direction, the sample must be abraded by fine-grit sand or emery paper until it is translucent. Then the structure of the shell's calcite crystals or pores can be examined under a petrographic microscope. The calcite crystal structure of dinosaur eggshell can be classified by their effect on polarized light. Calcite is capable of acting as a polarizing light filter. When a microscopic thin section sample is rotated relative to polarized light it can eventually block all the light and seem opaque. This phenomenon is called extinction. Different varieties of dinosaur eggs with their different calcite crystal structures have different light extinction properties that can be used to identify and distinguish even eggs that seem very similar on the surface. To reconstruct the three-dimensional structures of the shell's pore channels scientists require a series of multiple radial sections.
Economist Adam Hanieh argues that, in the post-WWII era, the global capitalist system was destabilized by a wave of decolonization movements that swept through Africa, Asia, and Latin America. According to historian L. S. Stavrianos, inspired by the Soviet Union’s rapid socioeconomic progress, numerous revolutionary governments subsequently implemented state-planned economies and public ownership. In his autobiography, the former Prime Minister of India, Jawaharlal Nehru, proclaimed that "the presence and example of the Soviets was a bright and heartening phenomenon in a dark and dismal world." Political scientist Michael Parenti argues that these revolutionary governments implemented land reform and comprehensive programs for health, education, housing, and employment. By addressing the legacies of colonial exploitation and extreme poverty, he writes, these initiatives resulted in a historically unprecedented rise in the standard of living for hundreds of millions of people. Economist Samir Amin contends that these revolutionary governments also achieved progress in industrialization, economic equality, and the construction of modern states. According to economist Alice Amsden, World Bank data reveal a historic trend between 1950 and 1980: for the first time in recorded history, developing economies outpaced developed economies, achieving an average annual income growth of over 5% compared to 4% in the developed economies.
Sources: en.wikipedia.org
==== Cleveland Settlement ==== The United States' three largest pharmaceutical distributors, AmerisourceBergen, Cardinal Health and McKesson Corporation reached an agreement in October 2019 where they will pay two Ohio counties a combined US$215 million. As part of the deal, Israel drug manufacturer Teva will also provide US$20 million in cash and US$25 million worth of Suboxone, an opioid addiction treatment. Cuyahoga County (Cleveland) and Summit County (Akron) brought the suit in US Federal District Court (Northern District of Ohio). The settlement averted what would have been the first federal trial over the US opioid crisis. The defendants offered no admission of wrongdoing. More than 2,600 lawsuits against the US pharmaceutical industry are still in the offing. The plaintiffs in those cases said the Ohio settlement allows them time to attempt to negotiate a national settlement. It also pressures the participants to work out a deal, as every partial settlement diminishes the aggregate total the companies will be able to pay. The two counties had reached a similar settlement of US$20.4 million with Johnson & Johnson and its subsidiary Ethicon, Inc. earlier in October 2019.
=== Notable cases === Napoleon – French general and emperor Arthur Kornberg – Nobel laureate in Physiology or Medicine, 1959 Nicky Wire, Manic Street Preachers – bassist Alexandr Dolgopolov – tennis player Jonas Folger – MotoGP rider
The central pathways of metabolism described above, such as glycolysis and the citric acid cycle, are present in all three domains of living things and were present in the last universal common ancestor. This universal ancestral cell was prokaryotic and probably a methanogen that had extensive amino acid, nucleotide, carbohydrate and lipid metabolism. The retention of these ancient pathways during later evolution may be the result of these reactions having been an optimal solution to their particular metabolic problems, with pathways such as glycolysis and the citric acid cycle producing their end products highly efficiently and in a minimal number of steps. The first pathways of enzyme-based metabolism may have been parts of purine nucleotide metabolism, while previous metabolic pathways were a part of the ancient RNA world. Many models have been proposed to describe the mechanisms by which novel metabolic pathways evolve. These include the sequential addition of novel enzymes to a short ancestral pathway, the duplication and then divergence of entire pathways as well as the recruitment of pre-existing enzymes and their assembly into a novel reaction pathway. The relative importance of these mechanisms is unclear, but genomic studies have shown that enzymes in a pathway are likely to have a shared ancestry, suggesting that many pathways have evolved in a step-by-step fashion with novel functions created from pre-existing steps in the pathway.
In September of the same year, China and the U.S. announced they would "enact a nearly complete ban on the import and export of ivory." The Chinese market has a high degree of influence on the elephant population.
Today, it is considered that GBS pigment (granadaene) and hemolysin are identical or closely related molecules. Sialic acid is a notable virulence factor in S. agalactiae despite being found normally in humans and many other animals. By expressing an unusually high amount of sialic acid on the bacterial cell surface, S. agalactiae can subvert the innate immune system, convincing leukocytes that the bacteria are human cells.
Sources: en.wikipedia.org
Technetium (99mTc) mertiatide is a radiopharmaceutical medication used in nuclear medicine to image the kidneys. It is a renal imaging agent that is given by intravenous injection. It was approved for medical use in the United States in June 1990.
==== Gaeryang ganjang ==== Gaeryang-ganjang (개량간장, "modernized soy sauce"), referring to varieties of soy sauces not made of meju, is now the most widely used type of soy sauce in modern Korean cuisine. The word ganjang without modifiers in bokkeum (stir-fry), jorim (braised or simmered dishes), and jjim (steamed dishes) recipes usually mean gaeryang-ganjang. Another common name of gaeryang-ganjang is jin-ganjang (진간장, "dark soy sauce"), because gaeryang-ganjang varieties are usually darker in appearance compared to traditional hansik ganjang. Having been introduced to Korea during the era of Japanese forced occupation, garyang ganjang is also called Wae-ganjang (왜간장, "Wae soy sauce"). Korean Ministry of Food and Drug Safety's Food Code classifies gaeryang-ganjang into four categories by their method of production.
=== Japanese volunteers === Many former Imperial Japanese Army soldiers fought alongside the Việt Minh—perhaps as many as 5,000 volunteered their services throughout the war. These Japanese soldiers had stayed behind in Indochina after World War II concluded in 1945. The occupying British authorities then repatriated most of the rest of the 50,000 Japanese troops back to Japan. For those that stayed behind, supporting the Việt Minh became a more attractive idea than returning to a defeated and occupied homeland. In addition the Việt Minh had minimal experience in warfare or government so the advice of the Japanese was welcome. Some of the Japanese were ex-Kenpeitai who were wanted for questioning by Allied authorities. Giap arranged for them all to receive Vietnamese citizenship and false identification papers. Some Japanese were captured by the Việt Minh during the last months of World War II and were recruited into their ranks. Most of the Japanese officers who stayed served as military instructors for the Việt Minh forces, most notably at the Quảng Ngãi Army Academy. They imparted necessary conventional military knowledge – such as how to conduct assaults, night attacks, company/battalion level exercises, commanding, tactics, navigation, communications and movements. A few, however, actively led Vietnamese forces into combat. The French also identified eleven Japanese nurses and two doctors working for the Việt Minh in northern Vietnam in 1951. The Yasukuni Shrine commemorates a number of Japanese involved in the First Indochina War.
== History of method == The bacteria one-hybrid system has undergone numerous modifications since its inception in 2005. It ultimately arose as a variation of the bacteria two-hybrid system, conceived in 2000, which itself was inspired by the yeast one- and two-hybrid systems. Whereas the two-hybrid versions can assess both protein–protein interaction and protein–DNA interactions, the one-hybrid system specializes in the latter. Meng et al.’s B1H system differs from the two-hybrid version in two key respects. It uses a randomized prey library consisting of many (<2×108) unique potential target sequences and also adds a negative selection step in order to purge this library of self-activating clones. Although these ideas were borrowed from the original yeast one-hybrid system, they had not yet been applied to a bacterial host before 2005. As the technique grew in popularity, researchers amended their protocols to improve the B1H system. Designing the fusion construct (bait) to the omega, rather than the alpha, subunit of RNA polymerase has recently been favoured in order to improve the chimera’s stereochemistry and dynamic range. A zinc-finger domain on the fusion construct and its corresponding DNA target site, adjacent to the randomized prey sequence, has also been added to the increases affinity and specificity of protein–DNA interactions. This increased overall binding affinity allows for the characterization of even those DNA-binding domain proteins which interact weakly with a target sequence.
Sources: en.wikipedia.org
Dihexa is a synthetic peptide modeled on angiotensin IV. It is used in laboratory and animal research, not as an approved medicine. Human effects remain poorly characterized.
It is produced by chemical synthesis, not extracted from plants or animals. Its design is based on a naturally occurring peptide fragment. Suppliers sell it as a research chemical.
No, dihexa is a modified analog of angiotensin IV. The two share a structural relationship but differ in chemical details. Research on one does not automatically apply to the other.
Dihexa is a synthetic peptide analog of angiotensin IV, often described as an HGF mimetic in research literature. It is studied for effects on synaptic connectivity in laboratory models. It is not an approved medication.